![Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas]()
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomasNorden, Andrew D.; Schiff, David; Ahluwalia, Manmeet S.; Lesser, Glenn J.; Nayak, Lakshmi; Lee, Eudocia Q.; Rinne, Mikael L.; Muzikansky, Alona; Dietrich, Jorg; Purow, Benjamin; Doherty, Lisa M.; LaFrankie, Debra C.; Pulverenti, Julee R.; Rifenburg, Jennifer A.; Ruland, Sandra F.; Smith, Katrina H.; Gaffey, Sarah C.; McCluskey, Christine; Ligon, Keith L.; Reardon, David A.; Wen, Patrick Y. · Journal of Neuro-Oncology · 2015